Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR1 | P32241 | 3/20 | 0.48 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.47 |
| ▸ | TFPI | P10646 | 1/20 | 0.46 |
| ▸ | GLP1R | P43220 | 1/20 | 0.45 |
| ▸ | GCGR | P47871 | 1/20 | 0.45 |
| ▸ | GIPR | P48546 | 1/20 | 0.45 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.45 |
| ▸ | CALCR | P30988 | 3/20 | 0.45 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29856153 | 0.91 | TFPI (0.47) | VIPR1VIPR2TFPIGLP1RGCGR | |
| SCHEMBL30179580 | 0.91 | VIPR1 (0.53) | VIPR1VIPR2GLP1R | |
| SCHEMBL31462925 | 0.89 | VIPR1 (0.51) | VIPR1VIPR2TFPIGLP1RGCGR | |
| SCHEMBL8973565 | 0.89 | TFPI (0.50) | VIPR1VIPR2TFPI | |
| SCHEMBL30262128 | 0.88 | VIPR2 (0.52) | VIPR1VIPR2TFPIGLP1RGCGR | |
| SCHEMBL30512593 | 0.88 | VIPR1 (0.47) | VIPR1VIPR2CXCR4 | |
| SCHEMBL29473688 | 0.87 | TFPI (0.51) | VIPR1VIPR2TFPIGLP1RGCGR | |
| SCHEMBL30681588 | 0.87 | VIPR2 (0.49) | VIPR1VIPR2TFPI | |
| SCHEMBL29453356 | 0.87 | VIPR2 (0.52) | VIPR1VIPR2TFPI | |
| SCHEMBL30327333 | 0.86 | NPY4R (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113549143-B | Anti-tumor polypeptide Bax-BH3, fluorescent polymer nano micelle and preparation method and application thereof | 吉林大学 | 2022-05-27 | — | — | CN | disclosed |